All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention NIPER Raebareli, the most common co-covered peer. Source depth averages 2 original sources per story, versus 2.6 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Roche Pharma
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention NIPER Raebareli, the most common co-covered peer. Source depth averages 2 original sources per story, versus 2.6 across the same-window beat baseline. Their average consequence score of 5 runs below the beat's 6 for that window. We currently track 1 Biotech story that mention Roche Pharma, all published on March 19, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Roche Pharma. Shared-story counts are live from our verified record — not editorial picks.
Roche Pharma has entered into a strategic collaboration with NIPER Raebareli to enhance pharmaceutical education and research capabilities in India. This partnership aims to bridge the gap between academic research and industrial application through joint capability-building initiatives.
Roche Pharma is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.